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Signiﬁcant beneﬁts can be derived by heart failure patients from exercise training. This paper provides an evidence-based
assessment of expected clinical beneﬁts of exercise training for heart failure patients. Meta-analyses and randomized, controlled
trials of exercise training in heart failure patients were reviewed from a search of PubMed, Cochrane Controlled Trial Registry
(CCTR), CINAHL, and EMBASE. Exercise training improves functional capacity, quality of life, hospitalization, and systolic and
diastolic function in heart failure patients. Heart failure patients with preserved systolic function (HFnEF) participating in exercise
training studies are more likely to be women and are 5–7 years older than their systolic heart failure (CHF) counterparts. All
patients exhibit low functional capacities, although in HFnEF patients this may be age related, therefore subtle diﬀerences in
exercise prescriptions are required. Published works report that exercise training is beneﬁcial for heart failure patients with and
without systolic dysfunction.
1.Background
Exercisetraininghasbecomeanacceptedadjuncttherapyfor
patients with systolic heart failure. Recent data have shown
that exercise is considered beneﬁcial for heart failure patients
in terms of improved mortality and morbidity [1], quality
of life [2, 3], functional capacity [4], and improved cardiac
[5] and vascular function [6]. Characteristics of heart failure
patients who participate in community-based prevalence
and exercise training studies may be diﬀerent with the latter
likely to be younger and predominantly male [1, 4, 7, 8].
North American [9], European [10], and Australian [11]
guidelines on the use of exercise training in heart failure
patients have been developed, although subtle diﬀerences
exist between the various guidelines. Subtle diﬀerences may
also exist in the demographics of heart failure patients with
abnormal systolic function (CHF) and heart failure patients
with normal left ventricular ejection fraction (HFnEF). CHF
patients are normally deﬁned as having left ventricular
ejection fraction <50% and impaired diastolic ﬁlling, while
HFnEF patients have a normal (>50%) ejection fraction but
impaired diastolic ﬁlling.
The aims of this work were to review highlighted dif-
ferences between the demographics of heart failure patients
participating in prevalence studies and those completing
exercise training studies. Moreover demographic data were
presented for systolic heart failure patients and those with
heart failure with preserved systolic function. This work also
aimed to provide a clinical update on the beneﬁts of exercise
training in heart failure patients.
2. Methods
Data relating to exercise training protocols in heart failure
patients and subsequent outcomes were reviewed. Pub Med
(MEDLINE), Medscape, EMBASE, CINAHL, and Cochrane
Controlled Trials Registry were searched up until June 2010.
Reference lists of papers found were scrutinized for new
references. North American, European, and Australian heart
failure treatment guidelines were also sourced. Search terms
used were combinations of the terms exercise training, heart
failure, left ventricular dysfunction, physical training, resis-
tance training, guidelines, position stands, systematic reviews,2 Cardiology Research and Practice
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Figure 1: Age comparison of heart failure patients in both preva-
lence and exercise studies.
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Figure 2: Gender comparison of heart failure patients in both
prevalence and exercise studies.
meta-analysis, quality of life, functional capacity, mortality,
morbidity,cardiacfunction,heartfailurewithpreservedsystolic
function, safety, cytokine expression, brain natriuretic peptide,
and aerobic exercise. There were no restrictions on the year
of publication. We examined the latest editions of relevant
journals that were not yet available on electronic databases.
The reference lists of identiﬁed articles were subsequently
scrutinized and relevant articles were included. Information
on clinical variables was archived in a database. Community-
based heart failure prevalence studies were also sought to
draw comparisons with exercise studies in heart failure
patients.
Outcome measures fell into three categories: demo-
graphics, clinical measures, and public health issues. Demo-
graphics: age and gender of heart failure patients enrolled
in community-based prevalence versus exercise training
studies. Clinical measures: mortality and morbidity rates,
functionalcapacity,qualityoflife,cardiacfunction,cytokine,
and brain natriuretic peptide (BNP) expression in those
who did and did not undertake exercise training. Pub-
lic Health: number needed to treat, cost-eﬀectiveness,
safety, and minimization of adverse events during exercise
training.
3. Results
3.1. Demographics of Heart Failure Patients in both the
Community and in Exercise Training Studies.. Heart failure
patients who participate in exercise training research tend
to be younger (Figure 1) and twice as likely to be male
(Figure 2) compared to those heart failure patients studied
in prevalence research [1, 12]; the latter appear to provide
a better representation of heart failure patients in the
community, suggesting exercise studies may be prone to
participant selection bias.
Evidence suggests younger, male heart failure patients
are more likely to participate in exercise training due to
possible selection bias.
3.2. Demographics of CHF and HFnEF Patients Participating
in Exercise Training Studies.. Data from exercise training
studies of heart failure patients [4] reports CHF patients are
younger, mean 59±7y ears,andmorelikelytobemale(79%)
comparedtoHFnEFpatients,meanage65±5yearsand50%
male.
Evidence suggests CHF patients participating in exer-
cise training are younger and more likely to be male.
3.3. Clinical or Prognostic Characteristics
3.3.1.MortalityandHospitalizationBeneﬁts. Ameta-analysis
of exercise training programs in heart failure patients
(ExTraMATCH) reported beneﬁts in terms of mortality and
hospitalization [1]. A subanalysis of this study revealed
the reduction in overall and cardiac mortality and hos-
pitalization appears to be more likely in sicker patients,
speciﬁcallythosewithlowerleftventricularejectionfraction,
New York Heart Association class III/IV, ischemic cardio-
myopathy, lower peak VO2, and those over 60 years of age.
In terms of these exercise training program characteristics,
these mortality beneﬁts appear to be more apparent in
those patients that adhere to an exercise training program
for 28 weeks or more [1]. All studies included in the
ExTraMATCH meta-analysis used cycling as the training
modality. In comparison the largest (2,300 patients) ran-
domized,controlledstudyofexercisetraininginheartfailure
patients to date, the heart failure ACTION (HF-ACTION)
study [8], reported nonsigniﬁcant reductions in mortality
and hospitalization, especially in those who do not have
factors highly prognostic of mortality. Speciﬁcally, duration
of baseline cardiopulmonary exercise testing, left ventricular
ejection fraction, Beck Depression Inventory II score, and
history of atrialﬁbrillation orﬂutterwereidentiﬁed ashighly
prognostic of the primary endpoint of all-cause mortality or
hospitalization. After adjusting for prognostic hence exercise
training was found to reduce the incidence of all-cause
mortality or all-cause hospitalization by 11%. The data
from ExTraMATCH and HF-ACTION appear to contrast
one another, while the former showed a mortality beneﬁt
that was most obvious in the sickest patients, the latter only
showed a mortality beneﬁt once the patients with prognostic
symptoms had been removed from the analysis.Cardiology Research and Practice 3
Evidence equivocal for mortality and hospitalization
beneﬁtsandalsowhetherdiseaseseveritypredictswhich
patients may beneﬁt most.
3.3.2. Functional Capacity. Meta-analysis reported that heart
failure patients can typically expect to improve their func-
tional capacity by 15%–17% following exercise training [4]
and this is a powerful predictor of prognosis in this popu-
lation [13]. Peak VO2 values >13-14mL/kg/min may confer
a 50% cardiac mortality reduction, while a 1mL/kg/min
increase may be associated with a 10% lower cardiac mortal-
ity [14]. Peak VO2 changes appear to be independent of the
type of exercise training undertaken, for example, aerobic,
intermittent or resistance training [4]. In comparison, the
(HF-ACTION)study[8]reportedonlya4%improvementin
peak VO2. Meta-analysis data was generated from generally
smaller, single site studies which often had facilitated good
short-term exercise training adherence rates. HF-ACTION
trial authors reported poor adherence in the early part of the
trainingprogram,andthemulticentrestudydesignmayhave
aﬀected the magnitude of change in peak VO2.M o r e o v e r ,
the meta-analysis data was generated mainly from short (<3
month) duration studies with only two studies >12 months
duration[15,16],whileHF-ACTIONreportedboth3month
and 12 month data. Twelve months is a diﬃcult period
to retain patients, due to either attrition, illness, or death,
and also maintain exercise adherence in those who do not
withdraw from the study. It has been suggested that exercise
training studies tend to overestimate the size of change
in peak VO2 of exercise training participants [17], due to
variations in patient motivation and the impracticality of
blinding exercise training subjects. The more robust design
of HF-ACTION may have minimized the overestimation of
peak VO2 and therefore changes were smaller, but perhaps
more reliable. Only one published exercise training study
in HFnEF has provided functional capacity data to date
suggesting the size of the change in peak VO2 may be similar,
or even greater, to that seen in CHF patients.
Evidence suggest functional capacity undoubtedly
improves, but what is uncertain is the size of change in
Peak VO2 which is likely to be between 4%–15%.
3.3.3. Quality of Life (QOL). I nas y s t e m a t i cr e v i e wo f
exercise training in heart failure patients, QOL assessment
w a si m p r o v e di n1 1o f1 6r a n d o m i z e dc o n t r o l l e ds t u d i e s[ 2].
A more recent meta-analysis of 35 randomized controlled
trials, reported that heart failure patients can expect an
improvement of nearly 10 points in Minnesota living
with heart Failure Questionnaire scores following exercise
training [3].
Evidence is unequivocal for improvement in quality of
life.
3.3.4. Cardiac (Systolic) Function. A recent meta-analysis
[5] showed that exercise training improved left ventricular
ejection fraction (LVEF), end-diastolic volume (EDV), and
end-systolic volume (ESV) in patients with heart failure.
The weighted mean diﬀerence (WMD) of LVEF was sig-
niﬁcantly improved after aerobic exercise training (9 trials,
538 patients, WMD = 2.59%; 95% conﬁdence interval (CI)
1.44% to 3.74%), EDV (371 patients; WMD = −11.49mL;
95% CI −19.95 to −3.02mL), and ESV (371 patients; WMD
= −12.87mL; 95% CI −17.80 to −7.93mL. The authors
concluded that aerobic training, but not combined aerobic
and strength training, or isolated strength training reverse
LV remodelling in clinically stable individuals with heart
failure. Other data suggest that high intensity (95% peak
heart rate) aerobic interval walking will confer even greater
improvements in systolic function (baseline LVEF 28%,
posttraining LVEF 38%) [18].
Evidence suggests exercise training will improve systolic
function and should be predominantly aerobic, and
if tolerated, intermittent high intensity, in nature as
this will convey the greatest improvements in systolic
function.
3.4. Cardiac (Diastolic) Function. Published randomized,
controlled trials of exercise training in heart failure patients
with outcome measures of diastolic function, assessed by
tissue Doppler have reported variable results. The work
of Belardinelli [15] showed improvements in isovolumic
relaxation time (ms), early and late diastolic ﬁlling in a
2-month exercise training study of heart failure patients
with moderate-severe systolic function. Similarly improved
left ventricular diastolic stiﬀness [19] and reduced ﬁlling
pressure (E/Ea ratio) [18] in heart failure patients has
been reported in two other randomized, controlled trials of
exercise training.
Evidence suggests exercise training may enhance dias-
tolic function.
3.5. Circulating Levels of Proinﬂammatory Cytokines. Several
small randomized controlled trials have conducted analyses
of the eﬀect of diﬀerent forms of exercise training (high
versus low intensity, cycling versus electrical stimulation,
or respiratory muscle training) on serum measures of
proinﬂammatory cytokines in patients with congestive heart
failure. Interleukin-6 (IL-6) and tumour necrosis factor-
alpha are the two most commonly studied proinﬂammatory
cytokines [20–27]. A recent, elegant review clariﬁed the role
of IL-6 as a fuel (glucose) sensor [28]. As glucose metabolism
may be aﬀected in heart failure patients, especially during
exercise Pederson’s review may explain some of the varied
eﬀects of exercise training on IL-6.
Evidence—equivocal for reducing systemic levels of
inﬂammatory cytokines.
3.6. Brain Natriuretic Peptide (BNP) Levels. BNP levels are
also raised in the circulation of patients with chronic heart
failure (CHF) and may be related to disease severity or
poor management [29]. B-type natriuretic peptide (BNP)
is a cardiac neurohormone released as pre-pro-BNP and
then enzymatically cleaved to N-terminal-proBNP and BNP4 Cardiology Research and Practice
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Figure 3: Clinical or prognostic markers of change in heart failure
patients undertaking exercise training.
upon ventricular myocyte stretch. Blood measurements of
BNP have been used to identify patients with heart failure
[29, 30]. Currently, BNP assay is used as a diagnostic
and prognostic aid in congestive heart failure. In general,
a BNP level <100pg/mL excludes acutely decompensated
heart failure [29] .Ar e c e n ts y s t e m a t i cr e v i e wi no r d e rt o
establish whether exercise training of CHF patients has
an eﬀect on circulating BNP levels [31]. Meta-analysis of
randomized, controlled trials showed that exercise training
hadafavourableeﬀectonBNP−79pg/mL95%C.I.(−141to
−17) P = .01 and NT-proBNP −621pg/mL 95% C.I. (−844
to −398) P<. 00001. Two of the included studies had low
weekly energy expenditure (<400Kcal/week) and changes in
BNP and NT-pro-BNP were not signiﬁcant in these studies
[32, 33]. Patients who did not undergo training showed no
changes, suggesting blunting of adrenergic overactivity and
of natriuretic peptide overexpression [31].
Evidence unequivocal that B-type natriuretic pep-
tides are reduced following exercise training, more-
over a minimum weekly energy expenditure (circa
400Kcal·week−1) may be required to elicit changes in
B-type natriuretic peptides.
A summary of clinical markers of heart failure prognosis
can be seen in Figure 3.
3.7. Public Health Issues
3.7.1. Number Needed to Teat (NNT) to Prevent 1 Death. As
peak VO2 is a strong predictor of prognosis [13] and heart
failure patients undertaking exercise training may expect a
4%–15% improvement in peak VO2. An associated mortality
beneﬁt has been reported [1, 15], although HF-ACTION
data suggest these beneﬁts remain equivocal. A systematic
review calculated the number of heart failure patients that
need to undertake exercise training in order to prevent one
death is 17 over two years [1]. This value corresponds to 34
patients over a 12 month period.
Evidence suggests that 34 heart failure patients need
to be provided with exercise training for 12 months
to prevent one death from exercise training over this
period.
3.7.2. Cost-Eﬀectiveness. Cost of treatment will always be a
consideration in clinical decision making. Table 1 describes
the estimated cost-eﬀectiveness of three therapies for heart
failure. To highlight the example the cost has been calculated
for conducting a heart failure speciﬁc exercise program in
Australia(inmid-2010),inbothasupervisedhospitalsetting
a n dh o m e - b a s e ds e t t i n g( Table 1). A salary of AUS$ 60K p.a.
for a full-time graduate exercise physiologist is typical, and
would be required to manage 34 patients, however start-up
equipment costs of AUS$ 5–10K have not been included
in the estimation as these and other ongoing costs have
been excluded. A home exercise program may require only
1 day per week of the same exercise physiologist to telephone
patients to verify progress, but little or no equipment—the
next section addresses home exercise in more detail. We have
used examples cited on the University of Toronto’s evidence-
based medicine website [34] of trials of a beta-1 selective
blocker [35] and the diuretic Aldactone [36]. When we
compare treatment costs to prevent mortality in one patient,
we can see that hospital-based exercise is comparable in
cost to beta-blockade but noticeably less cost-eﬀective than
Aldactone, while home exercise training is clearly more cost-
eﬀective than beta-blockade but not Aldactone.
Evidence suggests exercise training, especially home-
based, is a cost eﬀective adjunct treatment.
3.7.3.Safety. Exercisemayincreasetheriskofsuddencardiac
death [38]. While both exercise training and the heart
failure condition each convey an increased risk of sudden
death or adverse event, the published works in this ﬁeld
are yet to identify as single death that could be directly
linked to exercise exertion in over 100,00 patient-hours of
exercise training [4]. For this reason odds ratios for heart
failure patients have not been calculated. Data from the HF-
ACTION trial were zero deaths per 1,000 exercise tests and
0.45 nonfatal major CV events per 1,000 exercise tests (95%
CI 0.11–1.81). Recent data suggest that although, sudden
cardiac death (SCD) and cardiac events are more prevalent
in the morning hours, data do not exist to suggest the time of
day exercise training is conducted may not increase the risk
of SCD or other adverse events [38].
Supervised outpatient trials may proﬀer better adherence
rates than home exercise, possibly due to poor motivation
and concerns about safety [39]. Strategies that improve
home exercise compliance require regular patient contact
and methods of verifying patient adherence. Nevertheless it
is possible to sustain peak VO2 and quality of life (QOL) in a
“Home”exerciseprogram12monthsafteroutpatientcardiac
rehabilitation discharge [16, 40]. A recent systematic reviewCardiology Research and Practice 5
Table 1: Relative costs of various treatments for one mortality avoided.
Treatment Number Needed to Treat per annum Estimated Cost (AUS$) per annum
Beta-Blockade [35]7 2 6 5 K
Aldactone (Spironolactone) [36]4 . 5 5 K
Hospital based exercise training [37]3 4 6 0 K
Home based exercise training N/A 12K
Safety
Cost
Delivery
Number to
treat (NNT)
• Date suggests exercise is safe
• Time of day may not aﬀect safety
• Ongoing costs - salaries
• Start-up costs equipment
• Hospital
• Home
• Hopsital then home
Figure 4: Public health issues associated with exercise training
programs for heart failure patients.
reported that home exercise for heart failure patients may
elicit similar magnitude of change in peak VO2 compared
to hospital based programs, although some of the data
was generated from combined hospital and home exercise
studies [40]. A tailored exercise program may optimise
health beneﬁts while minimising risk of exertional events.
Periodic measurement of functional capacity, either directly
or indirectly may protect against under- or overestimating
the optimal training intensity.
Evidence suggests exercise training is safe for heart
failure patients, but home exercise is most beneﬁcial
when it follows a supervised, hospital-based program.
A summary of public health issues related to heart failure
exercise training can be seen in Figure 4.
4. Discussion
A chronological history of exercise training for heart failure
patients makes interesting reading. Prior to the 1990’s the
advice almost unequivocally given to heart failure patients
was to avoid physical exertion. A handful of studies prior to
the 1990’s suggested exercise training was safe and possibly
beneﬁcial in reducing dyspnea and improving mood. In
the 1990’s and 2000’s numerous studies and several meta-
analyses have highlighted the importance of regular physical
activityinimprovingnotonlyimprovingphysicalﬁtnessand
quality of life, but also cardiac and blood vessel function and
systemicinﬂammatoryandneurohormonal markersofheart
failure. Moreover exercise appears to be safe and most people
with heart failure, with the exception of New York Heart
Association class IV and some other high risk-heart failure
patient categories, should be advised to regularly exercise.
The change in consensus of opinion towards safety and
eﬃcacy of exercise training was based upon data synthesis
from many small- to medium-sized trials. Notably, meta-
analysis [1] had suggested signiﬁcant mortality and hospital-
ization beneﬁts could be derived from exercise training heart
failure patients, however closer analysis of the data suggested
statistical signiﬁcance of mortality and hospitalization was
absent if the study of Belardinelli [15]w a sr e m o v e df r o m
the meta-analysis. Then, in late 2008 data was released
from the HF-ACTION study [8] the largest (2,300 patients)
exercise training study of heart failure patients to date. HF-
ACTION reported nonsigniﬁcant reductions in mortality
and hospitalization. After adjusting for highly prognostic
predictors, exercise training was associated with modest
signiﬁcant reductions for both mortality and heart failure
hospitalization. These ﬁndings together with the cost and
eﬃcacy data presented in this paper suggest exercise has a
beneﬁcial role in the nonpharmacological management of
heart failure.
5. Conclusions
Diﬀerences exist in the demographics of participants of
prevalence and exercise training studies in heart fail-
ure patients. Exercise training is safe, eﬀective, and not
cost prohibitive. Evidence shows exercise training-induced
improvements are possible in many indicators of heart
failure patient prognosis; functional capacity, quality of
life, systolic and diastolic function, BNP and NT-pro-BNP
expression. Nevertheless it remains questionable whether
exercise training reduces cardiac deaths and hospitalisation
andwhetherdiseaseseveritypredictswhichpatientsaremost
likely to beneﬁt.
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